| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.009 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |